2 legendary ASX large-cap shares trading on hard-to-ignore valuations

These large stocks look good value to me.

ASX large-cap shares can be great investments due to their strong position in their industry and ability to deliver large profits.

With the S&P/ASX 200 Index (ASX: XJO) regularly hitting new all-time highs, it may be difficult to find investments that seem attractively priced.

But, there are a few areas of the market that look appealing.

I'm going to discuss two ASX large-cap shares that have seen their share prices decline over the past year, but their futures look promising.

A woman stands on a huge oversized wooden park bench with her arms outstretched towards the mountainous horizon in the distance.

Image source: Getty Images

Sonic Healthcare Ltd (ASX: SHL)

Sonic is a large, global pathology business with a presence in countries such as Australia, the USA, Germany, the UK, Switzerland and so on.

Over the past year, Sonic Healthcare's share price has fallen by 12%, compared to a 12% rise for the ASX 200.

It's understandable why the company has fallen due to a few factors, including inflation of costs and the loss of COVID-19 testing revenue.

But, I believe there are a number of positives that can help the company over the long-term. I'll mention a few of them now.

Sonic has made several acquisitions in Europe, particularly in Switzerland and Germany, to enhance its scale and presence in those regions. Sonic is currently working on unlocking synergies.

The ASX large-cap share has made equity investments in AI businesses, with those AI services potentially capable of improving Sonic's service and efficiencies.  

The last thing I'll point to is the ongoing solid organic base business revenue growth – in FY24 the growth rate was 6%.

According to the estimates on Commsec, the Sonic Healthcare share price is valued at under 22x FY26's estimated earnings with a forecast dividend yield of 4% (excluding franking credits).

Rio Tinto Ltd (ASX: RIO)

ASX iron ore shares can be opportunities when there is a significant weakness regarding the iron ore price. In 2024 to date, the Rio Tinto share price is down close to 20%.

Commodities can be cyclical opportunities if we buy when prices are low (and possibly sell when prices are higher).

There is no financial rule to say when the next rebound of the iron ore price will be, or by how much the price will rise.

However, there are some optimistic signs of a potential turnaround with President Xi Jinping urging China to strive to "achieve its annual economic and social development goals and tasks", raising market hopes for further stimulus, according to Trading Economics. It's also possible that China may soon cut interest rates for trillions of dollars of mortgages.

I'm also attracted to Rio Tinto's efforts to grow its copper exposure, which could be one of the most important commodities in the coming years because of its usage in things like electric vehicles and renewable energy.

The ASX large-cap share is valued at 10x FY26's estimated earnings with a possible fully franked dividend yield of 5.7% in FY26.

Motley Fool contributor Tristan Harrison has positions in Sonic Healthcare. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Man looking at two roads going in different directions.
Blue Chip Shares

CSL vs Telstra: Which ASX blue chip has the better outlook?

CSL and Telstra are two ASX blue chips with very different outlooks—here’s which one I’d pick as the better buy…

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering large dividend yields

These leaders offer investors significant investment income.

Read more »

Happy young woman saving money in a piggy bank.
Blue Chip Shares

This is the ASX share I'd trust with my money for the next 30 years

Three decades is an enormous investment horizon, but one business stands out to me.

Read more »

Man looking down and trying to work his laptop.
Blue Chip Shares

CBA vs Wesfarmers: Which looks best for a 50-year-old investor in 2026?

Which ASX blue chip—CBA or Wesfarmers—looks best right now for 50-year-old investors?

Read more »

Stacks of coins in ascending order with a plant on top, next to a piggy bank.
Blue Chip Shares

Droneshield vs BHP shares: Which ASX stock is better for long-term wealth?

I compare Droneshield and BHP shares to decide which looks the better bet to build long-term wealth for a 40-year-old…

Read more »

CEO of a company talking to her team.
Blue Chip Shares

CSL vs BHP shares: Should you swap after CSL's new CEO appointment?

Yesterday, CSL named Deborah Waterhouse as its next CEO. Should investors now pick CSL over BHP?

Read more »

Person holding blue chips.
Blue Chip Shares

Fortescue vs Coles shares: Which ASX blue chip wins this month?

Which delivers more long-term wealth potential: high-yielding Fortescue or steady Coles? Here’s my opinion — with all the key numbers…

Read more »

flying asx share price represented by businessman flying through the air
Blue Chip Shares

Ansell vs Ampol: Which outperforming ASX 200 stock can keep climbing in 2026?

Ampol and Ansell are both flying high, but one stands out for value, yield, and momentum in 2026—see which stock…

Read more »